Ventilatory effects of aerosolized kanamycin and polymyxin.
D000336:Aerosols; D006801:Humans; D007612:Kanamycin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D008171:Lung Diseases / Q000188:drug therapy*; D011113:Polymyxins / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D012123:Pulmonary Ventilation / Q000187:drug effects; D012138:Respiratory Therapy / Q000009:adverse effects; D013147:Spirometry; D014692:Ventilation-Perfusion Ratio / Q000187:drug effects*
D000336:Aerosols; D011113:Polymyxins; D007612:Kanamycin